A Singapore Government Agency Website 

Should persons who had completed three doses of Sinovac-CoronaVac continue to receive a fourth dose of Sinovac-CoronaVac?



Persons who have received three doses of COVID-19 vaccines, of which two or more doses of comprise Sinovac-CoronaVac*, are recommended to receive a fourth dose of either the Pfizer-BioNTech/Comirnaty, Moderna/Spikevax or Novavax/Nuvaxovid vaccine to achieve minimum protection, unless medically ineligible for the abovementioned vaccines.


However, they can receive Sinovac-CoronaVac as their fourth dose if they choose to.


Those who received an mRNA or the Novavax/Nuvaxovid vaccine as their third dose should receive the fourth dose about five months thereafter.


Those who received the Sinovac-CoronaVac vaccine as their third vaccine dose should receive the fourth dose at three months thereafter, due to lower antibody levels generated by the third vaccine dose.


For now, Sinovac-CoronaVac vaccine continues to be included under the National Vaccination Programme (NVP)^. Pfizer-BioNTech and Moderna have successfully obtained full registration. However, if there is no application for Sinovac-CoronaVac vaccine to be fully registered, NVP will lapse for Sinovac-CoronaVac vaccine, by 30 September 2024. Nevertheless, Sinovac-CoronaVac vaccine will continue to be available at private clinics which have applied to use it under the Special Access Route (SAR).


*Recommendations for Sinovac-Coronavac should similarly apply to Sinopharm

^Under the National Vaccination Programme, vaccination is free for all Singaporean Citizens, Permanent Resident, Long Term Pass Holders and certain Short Term Pass holders.

Let other citizens know if this answer was helpful
Did this answer your question?

Can’t find what you’re looking for?